Immune Checkpoint Inhibition as a Strategy in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
The treatment of locally advanced rectal cancer (LARC) has seen major advances over the past 3 decades, with multimodality treatment now standard of care. Combining surgical resection with radiotherapy and/or chemotherapy can reduce local recurrence from around 20% to approximately 5%. Despite impro...
Main Authors: | Catherine R. Hanna, Séan M. O’Cathail, Janet Graham, Richard Adams, Campbell S.D. Roxburgh |
---|---|
Format: | Article |
Language: | English |
Published: |
Innovative Healthcare Institute
2021-05-01
|
Series: | Journal of Immunotherapy and Precision Oncology |
Subjects: | |
Online Access: | https://jipo.org/doi/pdf/10.36401/JIPO-20-31 |
Similar Items
-
A Review of Scheduling Strategies for Radiotherapy and Immune Checkpoint Inhibition in Locally Advanced Rectal Cancer
by: Lydia Melissourgou-Syka, et al.
Published: (2023-11-01) -
Rectal stimulation with prebiotics and probiotics before ileostomy reversal: a study protocol for a randomized controlled trial
by: Marília Marcelino, et al.
Published: (2023-01-01) -
Rectal dosimetry in intracavitary applications of cervix carcinoma: Comparison of two methods
by: Baucal Milutin, et al.
Published: (2002-01-01) -
Radiation Proctitis and Management Strategies
by: Dushyant Singh Dahiya, et al.
Published: (2022-01-01) -
The role of rectal sparing devices in post-prostatectomy
radiotherapy: a review article
by: Arezoo Mehrabian, et al.
Published: (2023-03-01)